Clinical trial Recruiting at 11 sites Interventional Ages 18 to 65

Electrical stimulation to help regenerate injured nerves

Official title: Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Run by Epineuron Technologies Inc. · NCT05721261 · Data updated 2026-11-12

This study is testing a new electrical stimulation treatment to see if it can help people with injured nerves recover better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment110 (estimated)
SponsorEpineuron Technologies Inc.
Industry-sponsored
Locations15 sites (Gainesville, Florida and 14 other locations)
StatusRecruiting
StartedAugust 11, 2023
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedMarch 16, 2026
Trial IDNCT05721261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with acute peripheral nerve injuries.

Probably not a fit

Patients with peripheral neuropathy or those who have any active implanted devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a novel temporary peripheral nerve stimulation system designed to deliver a single dose of electrical stimulation therapy for one hour. The study aims to assess the safety and effectiveness of this intervention in patients with peripheral nerve injuries. Participants will be randomly assigned to receive either the active stimulation or a sham treatment to compare outcomes. The goal is to determine if this approach can enhance nerve regeneration and recovery.

Why it matters

Potential benefit: If successful, this treatment could significantly improve recovery outcomes for patients with peripheral nerve injuries.

How similar studies have gone: While the approach is innovative, similar studies on electrical stimulation for nerve regeneration have shown promising results, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Peripheral nerve injury

Exclusion criteria:

* Peripheral neuropathy
* Patients with any active implanted device

Where it's running

  • University of Florida Health
    Gainesville, Florida, United States
    Recruiting
  • Orlando Health Jewett Orthopedic Institute
    Orlando, Florida, United States
    Recruiting
  • Louisiana State University Health Sciences Center
    New Orleans, Louisiana, United States
    Recruiting
  • John Peter Smith Hospital
    Fort Worth, Texas, United States
    Recruiting
  • Saint John Regional Hospital
    Saint John, New Brunswick, Canada
    Recruiting
  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting
Show 9 more locations
  • St. Joseph's Healthcare Hamilton
    Hamilton, Ontario, Canada
    Recruiting
  • Southlake Health
    Newmarket, Ontario, Canada
    Recruiting
  • Humber River Health
    Toronto, Ontario, Canada
    Recruiting
  • North York General Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Trillium Health Partners
    Toronto, Ontario, Canada
    Recruiting
  • The Curtis National Hand Center
    Baltimore, Maryland, United States
    Completed
  • WellSpan Health
    York, Pennsylvania, United States
    Completed
  • University of Alberta Hospital
    Edmonton, Alberta, Canada
    Completed
  • Roth | McFarlane Hand & Upper Limb Centre
    London, Ontario, Canada
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.